Marilyn Bloovol

All filings by Marilyn Bloovol on record concern The Canadian Bioceutical Corporation. In total, 7 filings cover trades dated from 21 October 2016 to 17 October 2017.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 17 October 2017, reports a share grant of €34k in The Canadian Bioceutical Corporation. Typically, a trade is published a median of 3 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.